MedCity News December 22, 2024
Marissa Plescia

Walgreens is reportedly exploring selling itself to private equity firm Sycamore Partners. It might be the right decision for the company, some experts say.

Is anyone surprised that Walgreens is looking to sell itself — reportedly to private equity firm Sycamore Partners?

Walgreens has been losing a lot of greenbacks lately: a whopping $8.6 billion of them in fiscal 2024. Its foray into primary care has been a challenge forcing it to close a series of VillageMD clinics nationwide. Even its pharmacy business has faced competition from nimble, online pharmacy retailers like Amazon Pharmacy and Mark Cuban’s Cost Plus Drugs and fallen casualty to drug prices being negotiated.

And investors have paid attention to its missteps. Over the past five...

Today's Sponsors

LEK
ZeOmega

Today's Sponsor

LEK

 
Topics: Pharma, Pharma / Biotech
Building Resilience: CDMO Strategies for Drug Supply Chain Stability
STAT+: How Trump’s tariffs may raise health care costs, from medical devices to prescription drugs
ASHP to CMS: 'Change course' on drug pricing
Many independent pharmacists will not stock drugs in the price negotiation program
Measuring Progress for Life Sciences: Trust, Patient Access, and Prevention at a Fork in the Road of Public Health

Share This Article